NEOTOPASE-G

NEOTOPASE-G

202206-0253 • 675 Views • Box of 10 blisters × 10 film-coated tablets.
COMPOSITION

Each film-coated tablet contains:

Active ingredient:

Pancreatin 170 mg
Simethicone 84.433 mg

Excipients: Microcrystalline cellulose pH 101, povidone K30, colloidal silicon dioxide, crospovidone, HPMC 606 (hypromellose), PEG 6000 (polyethylene glycol), talc, titanium dioxide, yellow No. 4, blue No. 1.

Neotopase-G helps to transform food; supports treatment of indigestion, flatulence and distention.

POSOLOGY, METHOD OF ADMINITRATION

Dosage

Adult: 1 - 2 film-coated tablets × 3 times/day. 

Children from 7 to 14 years olds: 1 film-coated tablet × 3 times/day.

ADMINISTRATION

Neotopase-G is administrated orally, swallowed whole tablet, not be chewed or crushed, taking after meals or when having the symptoms of indigestion, flatulence. 

CONTRAINDICATIONS

In children aged 15 years and under with cystic fibrosis. 

Hypersensitivity to the active substance (pancreatin and simethicone) or to any of the excipients listed in “COMPOSITION”.

WARNINGS AND PRECAUTIONS

Hyperuricaemia and hyperuricosuria have been reported to occur in cystic fibrosis patients; pancreatin extracts contain a small amount of purine which might, in high doses, contribute to this condition.

Neotopase-G film-coated tablets contain Yellow No. 4 (i.e. Tartrazine (E 102)) which may cause allergic reactions.

PREGNANCY AND LACTATION

Pancreatin 

Pregnancy 

For pancreatic enzymes no clinical data on exposed pregnancies are available. Animal studies show no evidence for any absorption of porcine pancreatic enzymes. Therefore, no reproductive or developmental toxicity is to be expected. Caution should be exercised when prescribing to pregnant women.

Lactation

No effects on the suckling child are anticipated since animal studies suggest no systemic exposure of the breast-feeding woman to pancreatic enzymes. Pancreatic enzymes can be used during breast-feeding.

If required during pregnancy or lactation, pancreatin should be used in doses sufficient to provide adequate nutritional status.

Simethicone

As simethicone is not absorbed, it is not anticipated that the drug product will have any adverse effects on pregnancy and lactation. However, as with all drugs, caution should be exercised in these conditions.

STORAGE CONDITION

In a dry place, below 30°C, protect from light.

SHELF LIFE

36 months from the manufacturing date. Do not use after the expiry use

Al/PVC blister. Box of 10 blisters × 10 film-coated tablets. 
Your comment

Similar products

MOTIBOSTON
Box of 10 blisters x 10 film-coated tablets
Contact Us
BOSMOTI
Box of 30 sachets x 1.5 g
Contact Us
RABEBOSTON
Box of 02 blisters x 14 enteric-coated tablets
Contact Us
ANTALOC
Box of 10 blisters x 07 enteric-coated tablets
Contact Us
NEXIPRAZ 40
Box of 02 blisters x 07 hard capsules
Contact Us
TRIMEBOSTON 300
Box of 3 of blister x 10 coated - tablets
Contact Us
BOSMECT
Box of 30 sachets × 3.8 g/sachet.
Contact Us
IMOBOSTON
Box of 10 blisters x 10 hard capsules.
Contact Us
OMERAZ 20
Box of 10 blisters x 07 capsules containing enteric coated pellets.
Contact Us
TRIMEBOSTON 100
Box off 05 blisters x 10 tablets.
Contact Us
19001910
Confirm information
Please confirm that you are a pharmacist, doctor, medical specialist,... and want to learn about the product. The information described here is only to help readers better understand the product, not for advertising or treatment purposes.